Sanofi Offers $2.5B For Zentiva
This article was originally published in The Pink Sheet Daily
Executive Summary
Bid ups the ante in takeover battle with Czech financial group.
You may also be interested in...
Sanofi-Aventis Increases Bid For Zentiva To Reach Central, Eastern Europe
Sanofi-Aventis continues pushing to expand with an increased offer for Zentiva, which markets OTC drugs and dietary supplements as well as Rx products in Central and Eastern Europe.
Sanofi-Aventis Increases Bid For Zentiva To Reach Central, Eastern Europe
Sanofi-Aventis continues pushing to expand with an increased offer for Zentiva, which markets OTC drugs and dietary supplements as well as Rx products in Central and Eastern Europe.
First Roche, Then Bristol: Who’s Next?
This first article in a series takes an in-depth look at which pharma/biotech partnerships have the right chemistry to morph from collaboration to merger/acquisition.